StockData
IRadimed Corp logo

IRadimed Corp (IRMD) stock

IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3054% above fair value
$82.31−1.14 (-1.37%)

Close on Nov 18, 2026Market cap $1.05BP/E 44.0Yield –

IRadimed revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

IRadimed's revenue for the twelve months ending Sep 30, 2026 was $89.34M, up 11.0% year over year. For fiscal 2025 it was $83.81M, up 14.4% from the year before. Over ten years it grew 10.2% a year on average. The highest annual figure on record is $83.81M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$83.81M+14.4%
FY2024Dec 31, 2024$73.24M+11.7%
FY2023Dec 31, 2023$65.56M+23.0%
FY2022Dec 31, 2022$53.30M+27.5%
FY2021Dec 31, 2021$41.81M+31.8%
FY2020Dec 31, 2020$31.72M-17.7%
FY2019Dec 31, 2019$38.52M+26.5%
FY2018Dec 31, 2018$30.44M+31.9%
FY2017Dec 31, 2017$23.08M-29.0%
FY2016Dec 31, 2016$32.50M+2.9%
FY2015Dec 31, 2015$31.59M+101.8%
FY2014Dec 31, 2014$15.65M+38.0%
FY2013Dec 31, 2013$11.34M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$24.20M+14.2%
Q2 FY2026Jun 30, 2026$20.47M+0.3%
Q1 FY2026Mar 31, 2026$21.98M+12.6%
Q4 FY2025Dec 31, 2025$22.69M+17.0%
Q3 FY2025Sep 30, 2025$21.20M+15.7%
Q2 FY2025Jun 30, 2025$20.41M+13.8%
Q1 FY2025Mar 31, 2025$19.51M+10.9%
Q4 FY2024Dec 31, 2024$19.39M+11.1%
Q3 FY2024Sep 30, 2024$18.33M+11.0%
Q2 FY2024Jun 30, 2024$17.93M+11.1%
Q1 FY2024Mar 31, 2024$17.60M+13.7%
Q4 FY2023Dec 31, 2023$17.45M+17.4%
Q3 FY2023Sep 30, 2023$16.50M+23.1%
Q2 FY2023Jun 30, 2023$16.13M+26.8%
Q1 FY2023Mar 31, 2023$15.48M+25.7%
Q4 FY2022Dec 31, 2022$14.86M+25.2%
Q3 FY2022Sep 30, 2022$13.41M+22.9%
Q2 FY2022Jun 30, 2022$12.72M+29.7%
Q1 FY2022Mar 31, 2022$12.31M+33.5%
Q4 FY2021Dec 31, 2021$11.87M+38.9%
Q3 FY2021Sep 30, 2021$10.91M+41.7%
Q2 FY2021Jun 30, 2021$9.81M+44.4%
Q1 FY2021Mar 31, 2021$9.22M+6.3%
Q4 FY2020Dec 31, 2020$8.55M-21.5%
Q3 FY2020Sep 30, 2020$7.70M-22.7%
Q2 FY2020Jun 30, 2020$6.79M-26.3%
Q1 FY2020Mar 31, 2020$8.68M+2.8%
Q4 FY2019Dec 31, 2019$10.89M+30.6%
Q3 FY2019Sep 30, 2019$9.96M+30.8%
Q2 FY2019Jun 30, 2019$9.23M+25.1%
Q1 FY2019Mar 31, 2019$8.44M+18.7%
Q4 FY2018Dec 31, 2018$8.34M+24.4%
Q3 FY2018Sep 30, 2018$7.61M+33.8%
Q2 FY2018Jun 30, 2018$7.38M+33.5%
Q1 FY2018Mar 31, 2018$7.11M+37.7%
Q4 FY2017Dec 31, 2017$6.70M+11.9%
Q3 FY2017Sep 30, 2017$5.69M–
Q2 FY2017Jun 30, 2017$5.52M–
Q1 FY2017Mar 31, 2017$5.16M–
Q4 FY2016Dec 31, 2016$5.99M–

More IRadimed figures

See a number that looks wrong?